| Metric | Q2 2014 | Q1 2014 | Q2 2013 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $23M | — | — | — | — |
| Op. Income | $8M | — | — | — | — |
| Gross Margin | 33.5% | — | — | — | — |
| Net Margin | 17.0% | — | — | — | — |
| EPS (Diluted) | $1.45 | — | — | — | — |
| Free Cash Flow | $3M | — | $2M | — | 46.9% |
| Item | Amount |
|---|---|
| REVENUE | $23M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $8M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $946.0K |
| SG&A Expenses | $15M |
| Other Expenses | $0 |
| Operating Expenses | $15M |
| Cost & Expenses | $31M |
| OPERATING INCOME | $8M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $6M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $4M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $4M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $4M |
| D&A | $3M |
| EBIT | $8M |
| EBITDA | $11M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $23M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $8M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $946.0K |
| SG&A Expenses | $15M |
| Other Expenses | $0 |
| Operating Expenses | $15M |
| Cost & Expenses | $31M |
| OPERATING INCOME | $8M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $6M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $4M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $4M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $4M |
| D&A | $3M |
| EBIT | $8M |
| EBITDA | $11M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $4M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$609.0K |
| Other Non-Cash Items | $11M |
| Change in Working Capital | -$9M |
| OPERATING CASH FLOW | $9M |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $40.0K |
| NET CASH FROM INVESTING | -$5M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$3M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$591.0K |
| NET CASH FROM FINANCING | -$591.0K |
| FREE CASH FLOW | $3M |
| Net Change in Cash | $3M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $6M |
| Short-Term Investments | $0 |
| Net Receivables | $19M |
| Inventory | $588.0K |
| Other Current Assets | $8M |
| TOTAL CURRENT ASSETS | $34M |
| PP&E (Net) | $128M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $7M |
| Other Non-Current Assets | -$768.0K |
| TOTAL NON-CURRENT ASSETS | $135M |
| TOTAL ASSETS | $168M |
| Account Payables | $14M |
| Short-Term Debt | $214.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $29M |
| TOTAL CURRENT LIABILITIES | $43M |
| Long-Term Debt | $85M |
| Deferred Revenue NC | -$71M |
| Deferred Tax Liabilities | $57.0K |
| Other Non-Current Liabilities | $71M |
| TOTAL NON-CURRENT LIABILITIES | $85M |
| TOTAL LIABILITIES | $148M |
| Common Stock | $27.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$3M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $24M |
| TOTAL STOCKHOLDERS' EQUITY | $20M |
| Minority Interest | $0 |
| TOTAL EQUITY | $20M |
| TOTAL LIABILITIES & EQUITY | $168M |
| Total Debt | $85M |
| Net Debt | $79M |
